Résultats: 628

    Prevención, diagnóstico y tratamiento de la enfermedad tromboembólica venosa en la paciente obstétrica. Guía de Práctica Clínica: Evidencias y Recomendaciones

    La finalidad de esta guía es establecer un referente nacional para orientar la toma de decisiones clínicas basadas en recomendaciones sustentadas en la mejor evidencia disponible a disposición del personal del primer, segundo o tercer nivel de atención con la intención de estandarizar las acciones n...

    Australian guidelines for the clinical care of people with COVID-19 - Australian National COVID-19 Clinical Evidence Taskforce

    This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...

    Prevención, diagnóstico y tratamiento de la influenza estacional. Guía de Práctica Clínica: Evidencias y Recomendaciones

    La finalidad de esta guía es establecer un referente nacional para orientar la toma de decisiones clínicas basadas en recomendaciones sustentadas en la mejor evidencia disponible. Esta guía pone a disposición del personal del primer, segundo y tercer nivel de atención las recomendaciones basadas en ...

    WHO antenatal care recommendations for a positive pregnancy experience Nutritional interventions update: Vitamin D supplements during pregnancy

    The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was first published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during pregna...

    WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment

    Since 2007, the guideline development process within the World Health Organization (WHO) has been overseen by the WHO Guidelines Review Committee (GRC), which follows internationally recognized standards such as the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach, to su...

    WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection

    The political declaration at the first United Nations (UN) high-level meeting on tuberculosis (TB) held on 26 September 2018 included commitments by Member States to four new global targets.3 One of these targets is to diagnose and treat 40 million people with TB in the 5-year period 2018–2022. The ap...

    WHO antenatal care recommendations for a positive pregnancy experience Nutritional interventions update: Multiple micronutrient supplements during pregnancy

    This updated recommendation is relevant to all pregnant women and adolescent girls receiving comprehensive antenatal care (ANC) in any healthcare facility or community-based setting, and to their unborn fetuses and newborns. The question was prioritized during the ANC guideline development process. In 20...

    WHO recommendations on drug treatment for non-severe hypertension in pregnancy

    Hypertensive disorders of pregnancy are an important cause of severe morbidity, long-term disability and death among both pregnant women and their babies, and account for approximately 14% of all maternal deaths worldwide. Improving care for women around the time of childbirth is a necessary step towards...

    WHO consolidated guidelines on tuberculosis. Module 1: prevention – tuberculosis preventive treatment

    About one fourth of the world’s population is estimated to be infected with the tuberculosis (TB) bacterium, and about 5–10% of those infected develop active TB disease in their lifetime. The risk for active TB disease after infection depends on several factors, the most important being the person’...

    Directrices unificadas de la OMS sobre el tratamiento de la tuberculosis farmacorresistente

    Las cepas del bacilo tuberculoso con farmacorresistencia (TB-DR) son más difíciles de tratar que las farmacosensibles y amenazan el progreso mundial hacia los objetivos establecidos por la Estrategia Fin de la TB, de la Organización Mundial de la Salud (OMS). Por lo tanto, existe una necesidad imperio...